Sanofi (SNY) Interest Expenses (2009 - 2026)

Sanofi (SNY) has 18 years of Interest Expenses data on file, last reported at -$208.4 million in Q1 2026.

• Quarterly Interest Expenses rose 6.99% year-over-year to -$208.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.7 billion (up 14.6% YoY) and the FY2025 annual result came in at $655.4 million, down 42.84% from the prior year.
• Interest Expenses improved to -$208.4 million in Q1 2026 per SNY's latest filing, from -$655.4 million in the prior quarter.
• The five-year high for Interest Expenses was -$98.8 million in Q1 2022, with the low at -$1.4 billion in Q4 2023.
• Average Interest Expenses over 5 years is -$388.2 million, with a median of -$224.1 million recorded in 2025.
• Year-over-year, Interest Expenses surged 64.13% in 2022 and sank 821.34% in 2023.
• Sanofi's Interest Expenses stood at -$151.0 million in 2022, then sank by 821.34% to -$1.4 billion in 2023, then gained by 17.58% to -$1.1 billion in 2024, then soared by 42.84% to -$655.4 million in 2025, then surged by 68.2% to -$208.4 million in 2026.
• Business Quant data shows SNY's Interest Expenses at -$208.4 million in Q1 2026, -$655.4 million in Q4 2025, and -$687.4 million in Q3 2025.